BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32048621)

  • 1. Promoter-associated DNA methylation & expression profiling of genes (
    Khongsti S; Shunyu BN; Ghosh S
    Indian J Med Res; 2019 Dec; 150(6):584-591. PubMed ID: 32048621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome DNA methylation profiling of oral cancer in ethnic population of Meghalaya, North East India reveals novel genes.
    Khongsti S; Lamare FA; Shunyu NB; Ghosh S; Maitra A; Ghosh S
    Genomics; 2018 Mar; 110(2):112-123. PubMed ID: 28890207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
    Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
    Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.
    Khor GH; Froemming GR; Zain RB; Abraham MT; Omar E; Tan SK; Tan AC; Vincent-Chong VK; Thong KL
    Int J Med Sci; 2013; 10(12):1727-39. PubMed ID: 24155659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort.
    de Freitas Cordeiro-Silva M; Stur E; Agostini LP; de Podestá JR; de Oliveira JC; Soares MS; Mendonça EF; Gouvea SA; Von Zeidler SV; Louro ID
    Mol Biol Rep; 2012 Dec; 39(12):10111-9. PubMed ID: 22936053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of differential promoter hypermethylated genes in primary oral squamous cell carcinoma.
    Khor GH; Froemming GR; Zain RB; Abraham MT; Thong KL
    Asian Pac J Cancer Prev; 2014; 15(20):8957-61. PubMed ID: 25374236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
    Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
    Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Random Forest and data integration identifies three dysregulated genes and enrichment of Central Carbon Metabolism pathway in Oral Cancer.
    Mukhopadhyay S; Ghosh S; Das D; Arun P; Roy B; Biswas NK; Maitra A; Majumder PP
    BMC Cancer; 2020 Dec; 20(1):1219. PubMed ID: 33317464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
    Kordowski F; Kolarova J; Schafmayer C; Buch S; Goldmann T; Marwitz S; Kugler C; Scheufele S; Gassling V; Németh CG; Brosch M; Hampe J; Lucius R; Röder C; Kalthoff H; Siebert R; Ammerpohl O; Reiss K
    BMC Cancer; 2018 Aug; 18(1):796. PubMed ID: 30081852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
    Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
    Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.